Our Paris region academic partners propose the following available technologies. Click on any offer to get full details.
By clicking on Request More Information, you will be invited to send an 'Expression of Interest'. You will be answered as soon as possible.
A very stable new formulation for topical anesthetics with rapid onset of action has been developed. It has been demonstrated that the existing topical anesthetics could be toxics especially in pediatry because of the use of prilocaine. It is proposed to develop the new formulation, free of prilocaine, in vitro stage to in vivo stage, through licence agreement or research cooperation agreement (ref TOFR20171117001)
A research lab in the Paris region has developed a collagen-based hydrogel. This patented hydrogel has been proven to accelerate wound healing when used as a drug vector. Biotech or medtech companies are requested in order to develop specific wound dressing applications such as anti-inflammation, pain relief, antibiotic effect via a license agreement or a technical cooperation agreement. (ref TOFR20171116001)
The French TTO (technology transfer office) offers a new gel for the treatment of burns due to the hydrofluoric acid.
The French public research centre is looking for a technical cooperation or a license agreement. (TOFR20180907001)
A major hospital and research group of the Paris region has designed and patented an innovative needle-free device for multiple injections of drugs. The French public research centre is looking for interested medtech corporates or biotechnology companies for a technical cooperation or a license agreement. (TOFR20180920001)
An innovative newborn-suitable galenic form has been set up for a vitamin-sensitive epilepsy drug. It has been designed and proved to be efficient by a French clinical research lab. The Technology Transfer Office (TTO) acting on behalf the clinical research team, is looking for pharmaceutical companies interested by a technical cooperation agreement or a licensing agreement. (TOFR20181025003)